IPC Main Group
A61P 5/00 Drugs for disorders of the endocrine system
Introduced: January 2000
Last revised: January 2006
Classification Context
- Section:
- HUMAN NECESSITIES
- Class:
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
- Subclass:
- SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
8 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61P 5/02 of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P 5/06 of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P 5/1 of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P 5/14 of the thyroid hormones, e.g. T3, T4
- A61P 5/18 of the parathyroid hormones
- A61P 5/24 of the sex hormones
- A61P 5/38 of the suprarenal hormones
- A61P 5/48 of the pancreatic hormones
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594